ArticleFrontiers in nutrition2026
Low vitamin D status and 10-year dementia risk in sensory-impaired adults: a propensity score-matched cohort study.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Magnesium deficiency and long-term incident dementia among COVID-19 survivors: a propensity score-matched cohort study.Frontiers in nutrition · 2026Article
- COVID-19 and long-term risk of incident laboratory-defined micronutrient deficiency in patients with type 2 diabetes: a multicenter propensity score-matched cohort study.Frontiers in nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sensory impairment is a strong modifiable risk factor for dementia; however, whether vitamin D deficiency (VDD) was associated with increased risk in this high-risk group remains unclear. Individuals with vision or hearing impairment are prone to VDD due to reduced sunlight exposure, making this question clinically relevant. Methods: From the TriNetX Global Collaborative Network, this retrospective cohort study identified adults aged ≥50 years with documented vision and/or hearing impairment and serum 25-hydroxyvitamin D [25(OH)D] measurement. Patients were classified into VDD group (<20 ng/mL) and control group (≥30 ng/mL). The index date was defined as the date of the first 25(OH)D measurement that met the cohort-specific threshold and satisfied all eligibility criteria. The primary outcome was incident dementia over a 10-year follow-up. Secondary outcomes included dementia subtypes (i.e., vascular dementia and Alzheimer's disease), cognitive impairment, osteoporotic fracture (positive control), healthcare visits (detection bias assessment), and recurrent VDD. Results: After propensity score matching, 158,382 patients were included in each cohort. Compared to the control group, the VDD group was associated with a significantly higher risk of incident dementia [hazard ratio (HR), 1.55; Conclusion: In this cohort study, VDD was associated with an increased risk of incident dementia in adults with vision and/or hearing impairment, with exploratory findings supportive of a graded pattern. Although residual confounding cannot be excluded, these findings raise the possibility that low vitamin D status may be a potentially modifiable contributor to dementia risk in sensory-impaired populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.